![]() Patients in the Mayo Clinic who were consecutively tested for MOG-IgG1 by live cell-based flow cytometry during their diagnostic workup were included. Objective To determine the positive predictive value (PPV) of MOG-IgG1 testing in a tertiary referral center.ĭesign, Setting, and Participants This diagnostic study was conducted over 2 years, from January 1, 2018, through December 31, 2019. Positive results on MOG-IgG1 testing by live cell-based assays can confirm a MOGAD diagnosis, but false-positive results may occur. Importance Myelin oligodendrocyte glycoprotein-IgG1–associated disorder (MOGAD) is a distinct central nervous system–demyelinating disease. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |